Trade AlloVir, Inc. - ALVR CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.35 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023512% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.00129% | ||||||||
| Overnight fee time | 22:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 9.65 |
| Open | 9.59 |
| 1-Year Change | 1310.29% |
| Day's Range | 9.29 - 9.79 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Feb 21, 2025 | 9.29 | -0.30 | -3.13% | 9.59 | 9.79 | 9.24 |
| Feb 20, 2025 | 9.65 | -0.41 | -4.08% | 10.06 | 10.06 | 9.65 |
| Feb 19, 2025 | 10.11 | 0.42 | 4.33% | 9.69 | 10.23 | 9.49 |
| Feb 18, 2025 | 9.53 | 0.04 | 0.42% | 9.49 | 9.90 | 9.49 |
| Feb 14, 2025 | 9.56 | -0.18 | -1.85% | 9.74 | 9.77 | 9.55 |
| Feb 13, 2025 | 9.49 | -0.10 | -1.04% | 9.59 | 9.96 | 9.46 |
| Feb 12, 2025 | 9.62 | 0.03 | 0.31% | 9.59 | 9.93 | 9.23 |
| Feb 11, 2025 | 9.59 | -0.07 | -0.72% | 9.66 | 9.74 | 9.37 |
| Feb 10, 2025 | 9.66 | -0.07 | -0.72% | 9.73 | 9.99 | 9.49 |
| Feb 7, 2025 | 9.77 | -0.17 | -1.71% | 9.94 | 10.00 | 9.77 |
| Feb 6, 2025 | 9.99 | 0.20 | 2.04% | 9.79 | 10.28 | 9.79 |
| Feb 5, 2025 | 10.22 | 0.29 | 2.92% | 9.93 | 10.31 | 9.93 |
| Feb 4, 2025 | 9.99 | 0.15 | 1.52% | 9.84 | 10.34 | 9.49 |
| Feb 3, 2025 | 9.79 | 0.40 | 4.26% | 9.39 | 9.95 | 9.04 |
| Jan 31, 2025 | 9.39 | 0.26 | 2.85% | 9.13 | 9.66 | 9.13 |
| Jan 30, 2025 | 9.40 | -0.12 | -1.26% | 9.52 | 9.93 | 9.40 |
| Jan 29, 2025 | 9.53 | 0.30 | 3.25% | 9.23 | 9.65 | 9.23 |
| Jan 28, 2025 | 9.39 | -0.15 | -1.57% | 9.54 | 10.02 | 9.20 |
| Jan 27, 2025 | 9.79 | -0.08 | -0.81% | 9.87 | 10.00 | 9.49 |
| Jan 24, 2025 | 9.99 | 0.30 | 3.10% | 9.69 | 10.14 | 9.60 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
AlloVir, Inc. Company profile
About Allovir Inc
AlloVir, Inc. is a late clinical-stage cell therapy company. The Company is engaged in developing allogeneic T-cell therapies to treat and prevent viral diseases. Its virus-specific T cell (VST) therapy platform enables to generate VSTs designed to restore immunity in patients with T cell deficiencies. Its product candidate includes Viralym-M (ALVR105), ALVR106, ALVR109, ALVR107 and ALVR108. Its lead product candidate, Viralym-M, is a multi- VST therapy targeting five viruses: BK virus (BKV), cytomegalovirus (CMV), adenovirus (AdV), Epstein-Barr virus (EBV), and human herpesvirus 6 (HHV-6). The ALVR106 is an allogeneic VST therapy developed to target diseases caused by four respiratory viruses: respiratory syncytial virus (RSV), influenza, parainfluenza virus (PIV), and human metapneumovirus (hMPV). Its LVR109 is an allogeneic VST therapy that targets severe acute respiratory syndrome coronavirus two (SARS-CoV-2).
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Allovir Inc revenues was not reported. Net loss increased from $69.8M to $172M. Higher net loss reflects Research and development increase from $46.1M to $100.1M (expense), Stock-based Compensation in SGA increase from $5.9M to $23.3M (expense), Stock-based Compensation in R&D increase from $3.6M to $20.6M (expense).
| Industry: | Bio Therapeutic Drugs |
1100 Winter Street
WALTHAM
MASSACHUSETTS 02451
US
News
Microsoft Stock Price Forecast for 2025 and beyond: Third party price target
We assess the likely level of the Microsoft stock price in 5 years, and possible drivers behind the stock’s past performance. Read on...
18:29, 7 February 2025
Ripple XRP price prediction: Third-party price target
Discover the ripple (XRP) price predictions for 2025 and beyond, with analyst price targets and CFDs trading strategies on Capital.com
15:29, 6 February 2025
Apple (AAPL) stock price forecast: third-party price target
We looked at the forecasts for Apple stock in 10 years to see where the price would likely be at that point and the challenges the company could face. Read more.
11:22, 6 February 2025
FARTCOIN price prediction: Third-party price target
Read our FARTCOIN price prediction for 2025 and beyond, with insights from third-party analysts and market experts
10:18, 29 January 2025
MELANIA coin ($MELANIA) price prediction: Third party price target
Read our MELANIA crypto price prediction for 2025 and beyond, with insights from third-party analysts and market experts.
11:33, 22 January 2025
TRUMP coin ($TRUMP) price prediction: third-party price target
Read our TRUMP crypto price prediction for 2025 and beyond, with insights from third-party analysts and market experts
10:52, 22 January 2025
Ethereum price prediction: Third party data round up
What is the outlook for ETH as a long-term investment?
16:37, 7 January 2025People also watch
Still looking for a broker you can trust?
Join the 690,000+ traders worldwide that chose to trade with Capital.com